Acorda Therapeutics Inc (fka ACORQ)

[surf1944]

6:11AM Acorda Therapeutics reports EPS in-line, beats on revs (ACOR) 24.74 : Reports Q2 (Jun) earnings of $0.27 per share, in-line with the Capital IQ Consensus Estimate consensus of $0.27; revenues rose 15.9% year/year to $75.7 mln vs the $72.17 mln consensus. The co is reiterating 2012 AMPYRA net sales guidance of $255-$275 mln as well as FY R&D and SG&A levels. For the quarter ended June 30, 2012, the co closed with cash, cash equivalents and short-term and long-term investments of $303.0 mln, up from $295.3 mln in the first quarter.